The Emory-CDC HIV/AIDS Clinical Trials Unit participates in the development and implementation of research from the following three HIV/AIDS networks:

• AIDS Clinical Trials Group (ACTG): Adult HIV therapeutic strategies, including HIV cure, and noninfectious and infectious comorbidities (TB, hepatitis)
• HIV Vaccine Trials Network (HVTN): Integrated HIV prevention strategies
• HIV Prevention Trials Network (HPTN): Vaccines to prevent HIV infection

Our research sites have participated in landmark HIV/AIDS network studies, such as:

• HVTN 502: the STEP study, a HVTN study that tested the safety and efficacy of a HIV vaccine
• HVTN 505: a HVTN study that tested an HIV vaccine regimen
• the Thai Trial: the RV 144 study; a study that tested the a combination of two vaccines 
• HPTN 052: a HPTN study that tested two prevention strategies against sexual transmission of HIV
• HPTN 061: a HPTN study that investigated the rate at of new HIV infections among Black MSMs
• HTPN 064: the Women's HIV SeroIncidence Study; a HPTN study that investigated the rate of new infections among women with high HIV risk
• A5095: a ACTG study comparing three anti-HIV treatment regimens
• A5142: a ACTG study comparing three anti-HIV treatment regimens

Scholars/fellows: If you are a student, recent graduate, or medical resident, you may be able to contribute to our research by becoming one of our fellows or scholars.  If interested, click on contact us to reach one of our site coordinators.